eli lilly ceo on quarterly earnings beat, pharma policy, and more
Published 5 years ago • 1.2K plays • Length 9:43Download video MP4
Download video MP3
Similar videos
-
5:53
eli lilly ceo on earnings and drug pricing
-
7:14
eli lilly ceo david ricks on q3 results: the underlying growth story is fantastic
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
1:49
here's a breakdown of big pharma earnings from merck, pfizer, eli lilly
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
4:12
eli lilly ceo: we're growing based on the back of our newest pharma products
-
2:34
eli lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
-
4:17
eli lilly ceo on q2 earnings and core business performance
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
9:11
eli lilly ceo: competition in pharma | mad money | cnbc
-
1:41
eli lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
-
4:45
supply chain pressures are rather modest in the pharma sector, says eli lilly ceo
-
5:50
eli lilly ceo: we expect to launch five new medicines in 2022
-
2:22
eli lilly ceo: we have 11 pipeline projects in obesity
-
4:39
eli lilly ceo reacts to q3 earnings miss, provides pipeline update
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
4:29
eli lilly ceo david ricks breaks down q1 earnings, obesity drug trial results
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
8:11
eli lilly ceo david ricks on q3 earnings beat, mounjaro strength